Immune Mediator Quantification
Immune Mediator Quantification - Related Videos
02:55
Quantification of Immune Mediator Levels in Human Mucosal Lining Fluid
0 Views •
2025
This video demonstrates the quantification of immune mediator levels in neonatal human nasal mucosal lining fluid extract. An electrochemiluminescence-based multiplex assay system measures these mediators by evaluating the intensity of emitted light when they are excited.
05:31
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
0 Views •
Cited by 4 •
2017
This protocol describes a noninvasive technique for the sampling of undisturbed mucosal lining fluid from the upper airways. It can be used to perform the quantification of in vivo levels of protein mediators, such as cytokines and chemokines, in subjects of all ages.
03:45
Quantification of Inflammatory Mediators in Infected Human Tissue-Derived Cells
0 Views •
2025
This video demonstrates the quantification of inflammatory mediators during infection by incubating human lung-tissue-derived immune cells with Haemophilus influenzae. Flow cytometry is used to measure cytokine fluorescence in labeled lymphocytes, correlating with the production of pro-inflammatory cytokines in response to bacterial infection.
01:40
Cell-mediated Immune Responses
0 Views •
2025
Overview The cell-mediated immune system is the host’s primary response against invasive bacteria and viruses that cause intracellular infections. It is also essential for fighting against and destroying cancer cells. Furthermore, the cell-mediated immune system plays a role in the rejection of organ transplants or graft tissue. The Innate Immune System Activates the Adaptive Immune System Phagocytic cells of the innate immune system, such as macrophages or dendritic cells, are the first to...
01:27
Cytotoxic T Cells-mediated Immune Response
0 Views •
2024
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce. Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
FAQs
The assay first uses selective binding between an immune mediator and a capture or detection antibody. That binding generates a measurable signal, whose intensity is compared with signals from standards containing known concentrations. The resulting comparison converts signal strength into an estimated analyte concentration, allowing immune activity or inflammation to be assessed across biological samples.
Capture and detection antibodies provide the selectivity needed to associate a measured signal with a particular cytokine, chemokine, or growth factor. Their binding establishes the connection between the target mediator and the assay readout. This specificity helps researchers distinguish changes in individual signaling molecules rather than treating overall signal intensity as a nonspecific measure of inflammation.
Multiplex platforms are useful when researchers need to examine several immune mediators within the same investigation, whereas an enzyme-linked immunosorbent assay focuses on measuring one mediator. Assessing multiple cytokines, chemokines, or growth factors can provide a broader view of an immune response. A single-analyte format remains appropriate when the study centers on one defined signaling molecule.
Standards provide reference measurements with which sample signals can be compared. Because signal intensity alone does not directly state concentration, the standards establish the relationship between assay response and the amount of mediator present. Applying that relationship to biological samples produces concentration estimates that can be compared across experimental conditions, immune states, or treatment groups.
A typical workflow selects a biological sample and an assay format suited to the mediator panel, applies capture or detection antibodies, measures the resulting signal, and compares that signal with standards. The investigator then interprets the estimated concentrations across samples or conditions. Choosing a single-analyte or multiplex format depends on whether one or many mediators are being examined.
In immunology and infection studies, measured mediator concentrations help characterize host responses to pathogens and distinguish different inflammatory states. Profiles of cytokines, chemokines, or growth factors can reveal how immune activity changes between experimental conditions. These measurements therefore support investigation of infection-associated responses, rather than relying only on broad observations of inflammation.
Comparing mediator concentrations before, after, or across treatment conditions can indicate whether immune activity or inflammation changes in association with an intervention. Repeated patterns among measured cytokines, chemokines, or growth factors may also support biomarker discovery and disease monitoring. The value of the result depends on consistent comparison of samples using the selected standards and assay format.